Lab value | Baseline | 1st admission | 2nd admission | 3 months after starting treatment | Reference value |
---|---|---|---|---|---|
BUN | 12 | 8 | 10 | 9 | 5–25 mg/dl |
Creatinine | 0.72 | 0.87 | 0.87 | 0.90 | 0.61–1.24 mg/dl |
GFR | > 60 | > 60 | > 60 | 87 | > 60 |
AST | 19 | 28 | 32 | 18 | 10–42 U/L |
ALT | 12 | 18 | 27 | 12 | 10–60 U/L |
ALP | 77 | 82 | 69 | 103 | 38–126 U/L |
INR | 1.00 | 0.92 | 0.96 | – | 0.88–1.15 |
PTT | 32 | 32 | 31 | – | 26–39 s |
WBC | 10.3 | 6.6 | 6 | 6.3 | 4.5–11.0 K/uL |
Hemoglobin | 13.0 | 14.6 | 13.4 | 15.4 | 13.2–17.5 g/dl |
Platelets | 163 | 203 | 187 | 213 | 140–450 K/uL |
ESR | 19 | 13 | 44 | 20 | 0–15 mm/h |
CRP | – | 21.9 | – | 2 | 0–10 mg/L |
C3 | – | 54.8 | – | 87 | 85–170 mg/dl |
C4 | – | < 2 | – | 7 | 16–40 mg/dl |
RF | – | 2460.0 | – | – | < 20 U/mL |
c-ANCA | – | < 1:20 | – | – | <  1:20 |
p-ANCA | – | 0 | – | – | 0–19 U/mL |
Cryoglobulin screen | – | Positive | – | Positive | Non-detected |
Cryoprecipitan IFE | – | Type II | – | Type II | – |
IGA cryprecipitate | – | 15 | – | – | 0 mg/dl |
IGG cryprecipitate | – | 97 | – | – | 0 mg/dl |
IGM cryprecipitate | – | 109 | – | – | 0 mg/dl |
QuantiFERON TB | – | Negative | – | – | – |
Hep B surface Ag | – | Positive | – | Positive | – |
Hep B core IgM Ab | – | Negative | – | Negative | – |
Hep B surface Ab | – | Negative | – | Negative | – |
Hep B NAAT |  | 530 IU/mL | – | Undetected | – |
Hep C Ab | – | Negative | – | – | – |
Hep A Ab IgM | – | Negative | – | – | – |
HIV 1 & 2 Ag/AB | – | Negative | – | – | – |